Bioavailability and pharmacokinetics of (poly)phenols following consumption of selected blueberries and a blueberry-rich protein bar by adult males and females: a randomized, crossover, controlled trial

IF 6.9 1区 医学 Q1 NUTRITION & DIETETICS American Journal of Clinical Nutrition Pub Date : 2025-04-01 DOI:10.1016/j.ajcnut.2025.01.028
Monique C Santana , Atul S Rathore , Preeti Chandra , Jessica L Everhart , Harry Schulz , Cheryl D Granillo , Mario G Ferruzzi , Massimo Iorizzo , Mary A Lila , Joscelin T Diaz , Colin D Kay
{"title":"Bioavailability and pharmacokinetics of (poly)phenols following consumption of selected blueberries and a blueberry-rich protein bar by adult males and females: a randomized, crossover, controlled trial","authors":"Monique C Santana ,&nbsp;Atul S Rathore ,&nbsp;Preeti Chandra ,&nbsp;Jessica L Everhart ,&nbsp;Harry Schulz ,&nbsp;Cheryl D Granillo ,&nbsp;Mario G Ferruzzi ,&nbsp;Massimo Iorizzo ,&nbsp;Mary A Lila ,&nbsp;Joscelin T Diaz ,&nbsp;Colin D Kay","doi":"10.1016/j.ajcnut.2025.01.028","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>It is commonly believed that higher nutrient content equates to healthier foods and that food processing lowers nutrient content, although bioavailability studies often indicate otherwise. Blueberries, a rich source of (poly)phenols with proven health benefits, provide a feasible model to evaluate phytochemical bioavailability following consumption of raw and processed fruits.</div></div><div><h3>Objectives</h3><div>This study evaluates the effect of processing on the bioavailability of (poly)phenols following consumption of 4 interventions: 2 blueberry varieties (i.e., Elliott and Olympia) selected based on differing (poly)phenol content and in vitro bioaccessibility, a (poly)phenol-rich protein bar providing an equivalent amount of blueberries, and a control beverage.</div></div><div><h3>Methods</h3><div>This blinded, randomized, 4-way crossover, controlled trial (<em>n</em> = 18; 42.06 ± 12.53 y; body mass index [BMI] 24.75 ± 2.97 kg/m<sup>2</sup>) fed 1 serving (150 g) of Elliott and Olympia blueberries and a (poly)phenol-rich protein bar containing 1 serving of Elliott blueberries, compared with a macronutrient-matched control beverage. (Poly)phenols and metabolites were analyzed in blood and urine over 48 h, with bioavailability and pharmacokinetics assessed via linear mixed-effects repeated measures ANOVA.</div></div><div><h3>Results</h3><div>Recovery of metabolites was similar following consumption of blueberry varieties of differing (poly)phenol composition, with higher total urinary recovery after Elliott blueberry relative to Olympia blueberry and protein bar (21% and 29%, respectively). Serum AUC was similar across berry-derived treatments, whereas differences in maximum concentration (C<sub>max</sub>) and time at maximum concentration (T<sub>max</sub>) were observed; for example, urinary recovery of 3-methoxycinnamic acid-4-O-glucuronide was similar following Elliott blueberry and protein bar (<em>P</em> = 1.00), whereas C<sub>max</sub> was 1.24 h later after Elliott blueberry compared with protein bar (T<sub>max</sub> = 3.84 compared with 2.60 h). Alternatively, C<sub>max</sub> for 3-(3-hydroxyphenyl)propanoic acid was higher following Elliott blueberry compared with Olympia blueberry and protein bar (26.63 and 25.32 ng/mL higher, respectively).</div></div><div><h3>Conclusions</h3><div>Differing berry (poly)phenol content and bioaccessibility only minimally affect bioavailability following consumption of blueberries relative to a blueberry-rich protein bar, suggesting (poly)phenol-dense foods, such as bars and snacks, could provide similar health benefits as raw fruits. Further studies using other crops are required to assess if these findings are translatable.</div><div>This trial was registered at <span><span>clinicaltrials.gov</span><svg><path></path></svg></span> as NCT04175106.</div></div>","PeriodicalId":50813,"journal":{"name":"American Journal of Clinical Nutrition","volume":"121 4","pages":"Pages 779-794"},"PeriodicalIF":6.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Clinical Nutrition","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002916525000644","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

It is commonly believed that higher nutrient content equates to healthier foods and that food processing lowers nutrient content, although bioavailability studies often indicate otherwise. Blueberries, a rich source of (poly)phenols with proven health benefits, provide a feasible model to evaluate phytochemical bioavailability following consumption of raw and processed fruits.

Objectives

This study evaluates the effect of processing on the bioavailability of (poly)phenols following consumption of 4 interventions: 2 blueberry varieties (i.e., Elliott and Olympia) selected based on differing (poly)phenol content and in vitro bioaccessibility, a (poly)phenol-rich protein bar providing an equivalent amount of blueberries, and a control beverage.

Methods

This blinded, randomized, 4-way crossover, controlled trial (n = 18; 42.06 ± 12.53 y; body mass index [BMI] 24.75 ± 2.97 kg/m2) fed 1 serving (150 g) of Elliott and Olympia blueberries and a (poly)phenol-rich protein bar containing 1 serving of Elliott blueberries, compared with a macronutrient-matched control beverage. (Poly)phenols and metabolites were analyzed in blood and urine over 48 h, with bioavailability and pharmacokinetics assessed via linear mixed-effects repeated measures ANOVA.

Results

Recovery of metabolites was similar following consumption of blueberry varieties of differing (poly)phenol composition, with higher total urinary recovery after Elliott blueberry relative to Olympia blueberry and protein bar (21% and 29%, respectively). Serum AUC was similar across berry-derived treatments, whereas differences in maximum concentration (Cmax) and time at maximum concentration (Tmax) were observed; for example, urinary recovery of 3-methoxycinnamic acid-4-O-glucuronide was similar following Elliott blueberry and protein bar (P = 1.00), whereas Cmax was 1.24 h later after Elliott blueberry compared with protein bar (Tmax = 3.84 compared with 2.60 h). Alternatively, Cmax for 3-(3-hydroxyphenyl)propanoic acid was higher following Elliott blueberry compared with Olympia blueberry and protein bar (26.63 and 25.32 ng/mL higher, respectively).

Conclusions

Differing berry (poly)phenol content and bioaccessibility only minimally affect bioavailability following consumption of blueberries relative to a blueberry-rich protein bar, suggesting (poly)phenol-dense foods, such as bars and snacks, could provide similar health benefits as raw fruits. Further studies using other crops are required to assess if these findings are translatable.
This trial was registered at clinicaltrials.gov as NCT04175106.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
成年男性和女性食用蓝莓和富含蓝莓蛋白棒后(多)酚的生物利用度和药代动力学:一项随机、交叉、对照试验
背景:人们普遍认为,营养含量越高,食品越健康,食品加工过程中营养含量越低,尽管生物利用度研究经常表明并非如此。蓝莓富含(多)酚,已被证实对健康有益,为评估食用生水果和加工水果后的植物化学生物利用度提供了可行的模型。目的:本研究在食用4种干预措施后,评估加工对(多)酚生物利用度的影响:根据不同的(多)酚含量和体外生物可及性选择2种蓝莓品种(即埃利奥特和奥林匹亚),提供等量蓝莓的(多)酚富含蛋白质棒和对照饮料。方法:采用盲法、随机、4向交叉、对照试验(n = 18;42.06±12.53 y;体重指数为24.75±2.97 kg/m2的参与者分别食用一份(150 g)埃利奥特蓝莓和奥林匹亚蓝莓,以及一份含有一份埃利奥特蓝莓的(多酚)富含蛋白质棒,与之相比,对照组饮料中含有大量营养成分。在48小时内分析血液和尿液中的(多)酚及其代谢物,并通过线性混合效应重复测量方差分析评估生物利用度和药代动力学。结果:食用不同(多)酚成分的蓝莓品种后,代谢产物的回收率相似,埃利奥特蓝莓的总尿回收率高于奥林匹亚蓝莓和蛋白质棒(分别为21%和29%)。曲线下的血清面积在浆果衍生处理中相似,但最大浓度(Cmax)和最大浓度时间(Tmax)存在差异;例如,3-甲氧基肉桂酸-4- o -葡萄糖醛酸的尿回收率在Elliott蓝莓和蛋白棒后相似(p=1.00),而Cmax在Elliott蓝莓和蛋白棒后1.24 h (Tmax=3.84 vs 2.60 h), 3-(3-羟基苯基)丙酸的Cmax在Elliott蓝莓和Olympia蓝莓和蛋白棒后更高(分别为26.63和25.32 ng/mL)。结论:食用蓝莓后,相对于食用富含蓝莓的蛋白质棒,不同的浆果(多)酚含量和生物可及性对生物利用度的影响微乎其微,这表明(多)酚密集的食物,如棒和零食,可以提供与生水果相似的健康益处。需要使用其他作物进行进一步的研究,以评估这些发现是否可转化。临床试验注册:NCT04175106 (https://clinicaltrials.gov/ct2/show/NCT04175106?term=19138&draw=2&rank=1)临床试验注册:NCT04175106 (https://clinicaltrials.gov/study/NCT04175106)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
12.40
自引率
4.20%
发文量
332
审稿时长
38 days
期刊介绍: American Journal of Clinical Nutrition is recognized as the most highly rated peer-reviewed, primary research journal in nutrition and dietetics.It focuses on publishing the latest research on various topics in nutrition, including but not limited to obesity, vitamins and minerals, nutrition and disease, and energy metabolism. Purpose: The purpose of AJCN is to: Publish original research studies relevant to human and clinical nutrition. Consider well-controlled clinical studies describing scientific mechanisms, efficacy, and safety of dietary interventions in the context of disease prevention or health benefits. Encourage public health and epidemiologic studies relevant to human nutrition. Promote innovative investigations of nutritional questions employing epigenetic, genomic, proteomic, and metabolomic approaches. Include solicited editorials, book reviews, solicited or unsolicited review articles, invited controversy position papers, and letters to the Editor related to prior AJCN articles. Peer Review Process: All submitted material with scientific content undergoes peer review by the Editors or their designees before acceptance for publication.
期刊最新文献
Diet Quality and All-Cause Mortality Among Individuals with Chronic Kidney Disease: A UK Biobank Cohort Study. Choline and betaine concentrations in plasma discriminate levels of dietary choline intake in healthy adults: analysis of a double-blind randomized crossover controlled feeding study. New International Classification of Diseases-11 Code for Diagnosis of Adult Undernutrition in Clinical Settings. Gestational diabetes, human milk oligosaccharide (HMO) concentrations, and their links to infant weight gain and the gut microbiome in a United States observational cohort. Foods of concern, cardiopreventive medication use and risk of cardiovascular diseases: a prospective study in the CARTaGENE cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1